Streetbeat News

Products Services

LSTA

Lisata Therapeutics (NASDAQ:LSTA) has completed patient enrollment for the pancreatic cancer cohort in its Phase 1b/2a CENDIFOX trial. The trial, led by Dr. Anup Kasi at The University of Kansas Cancer Center, is evaluating the safety and efficacy of certepetide in combination with FOLFIRINOX-based therapies for pancreatic, colon, and appendiceal cancers.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:36 pm

BP

RSG

Archaea Energy and Republic Services have launched a renewable natural gas plant in their Lightning Renewables joint venture. The Fort Wayne plant, the largest Archaea Modular Design in Indiana, processes up to 6,400 scfm of landfill gas, enough to heat over 25,000 homes.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:36 pm

IINN

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) has received its first purchase order for INSPIRA ART100 systems from Glo-Med Networks, Inc. The first units are expected to be shipped in Q4 2024, following recent FDA clearance.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:35 pm

CDXC

ChromaDex has announced the launch of Niagen+, a new product that has received FDA authorization. The product will be available in various forms including IV, shot, and push at clinics nationwide.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:34 pm

CLPS

CLPS Incorporation (NASDAQ:CLPS) has acquired Shell Infotech, expanding its client base and market share in Southeast Asia, and strengthening its IT competencies and service offerings. This move solidifies CLPS's commitment to global expansion.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:34 pm

OSIS

OSI Systems has received an $11 million order for its radiation monitoring solutions, indicating strong demand for its products in this sector.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:32 pm

ETHUSD

TONUSD

Toncoin (CRYPTO: TON) is poised for a potential 40% breakout, driven by strong technical indicators and its integration with Telegram's vast user base. The network has outperformed Ethereum in daily unique addresses recently, highlighting its growing adoption.

Portfolio Pulse from Khyathi Dalal

June 13, 2024 | 12:32 pm

WBUY

Webuy Global Ltd (NASDAQ:WBUY) has launched NEONE, a premium health supplement brand, marking its entry into the nutraceutical and longevity markets. NEONE focuses on high-quality, scientifically-backed supplements aimed at improving health and longevity. Despite the positive news, WBUY shares traded lower by 3.99% premarket.

Portfolio Pulse from Anusuya Lahiri

June 13, 2024 | 12:31 pm

WBUY

Webuy Global has announced a successful launch with plans to rapidly enter the global, multi-billion-dollar anti-aging and nutraceutical markets.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:30 pm

WBUY

Webuy Global has announced its entry into the nutraceutical and longevity market with the launch of its flagship brand NEONE, a premium health supplement.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 12:30 pm